Sleep homeostasis, seizures, and cognition in children with focal epilepsy

Maria H Eriksson1,2, Torsten Baldeweg1,2, Ronit Pressler3

  • 1Developmental Neurosciences Research & Teaching Department, UCL Great Ormond Street Institute of Child Health, London, UK.

Insights

Children with focal epilepsy maintain normal overnight sleep slow-wave activity (SWA) decline, preserving sleep-dependent memory consolidation. However, reduced early-night SWA may indicate disrupted sleep homeostasis, especially with a higher seizure burden.

Area of Science:

  • Neuroscience
  • Pediatric Neurology
  • Sleep Medicine

Background:

  • Childhood epilepsy is associated with cognitive impairments.
  • Sleep disruption is a common comorbidity in epilepsy.
  • Sleep homeostasis, reflected in slow-wave activity (SWA), plays a crucial role in cognitive function and memory consolidation.

Purpose of the Study:

  • To investigate the relationship between sleep disruption and cognitive impairment in childhood epilepsy.
  • To examine the effect of epilepsy on sleep homeostasis, measured by SWA.
  • To correlate SWA with cognitive performance, seizure activity, and EEG findings.

Main Methods:

  • Overnight EEG-polysomnography was used to measure SWA in 19 children with focal epilepsy and 18 age- and sex-matched controls.
  • SWA decline and memory consolidation gains with sleep were assessed.
  • Correlations were made with full-scale IQ, seizure frequency, and focal interictal discharges.

Main Results:

  • Children with focal epilepsy showed preserved overnight SWA decline and sleep-related memory consolidation compared to controls.
  • Early-night SWA was lower in epileptic patients than controls, particularly those with a higher seizure burden.
  • Full-scale IQ did not correlate with SWA measures; no difference in SWA was found between focal and non-focal electrodes.

Conclusions:

  • Overnight SWA decline is maintained in children with focal epilepsy, supporting preserved sleep-dependent memory consolidation.
  • Reduced early-night SWA in epilepsy may suggest impaired or immature sleep homeostasis, potentially linked to seizure burden.
  • Lower early-night SWA is associated with an increased likelihood of subsequent seizures.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
259
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
558
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
821
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
488
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
562
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
257